Valley National Advisers’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
5,000
| – | – | ﹤0.01% | 630 |
|
|
2025
Q1 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 656 |
|
|
2024
Q4 | $6K | Hold |
5,000
| – | – | ﹤0.01% | 605 |
|
|
2024
Q3 | $9K | Hold |
5,000
| – | – | ﹤0.01% | 531 |
|
|
2024
Q2 | $10K | Hold |
5,000
| – | – | ﹤0.01% | 610 |
|
|
2024
Q1 | $9K | Hold |
5,000
| – | – | ﹤0.01% | 654 |
|
|
2023
Q4 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 814 |
|
|
2023
Q3 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 722 |
|
|
2023
Q2 | $5K | Hold |
5,000
| – | – | ﹤0.01% | 677 |
|
|
2023
Q1 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 689 |
|
|
2022
Q4 | $3K | Hold |
5,000
| – | – | ﹤0.01% | 702 |
|
|
2022
Q3 | $3K | Hold |
5,000
| – | – | ﹤0.01% | 733 |
|
|
2022
Q2 | $6K | Hold |
5,000
| – | – | ﹤0.01% | 640 |
|
|
2022
Q1 | $8K | Hold |
5,000
| – | – | ﹤0.01% | 627 |
|
|
2021
Q4 | $9K | Buy |
+5,000
| New | +$9K | ﹤0.01% | 618 |
|